These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3137818)

  • 1. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction.
    Califf RM; Topol EJ; George BS; Boswick JM; Abbottsmith C; Sigmon KN; Candela R; Masek R; Kereiakes D; O'Neill WW
    Am J Med; 1988 Sep; 85(3):353-9. PubMed ID: 3137818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.
    Bovill EG; Terrin ML; Stump DC; Berke AD; Frederick M; Collen D; Feit F; Gore JM; Hillis LD; Lambrew CT
    Ann Intern Med; 1991 Aug; 115(4):256-65. PubMed ID: 1906692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy. The TAMI Study Group.
    Wall TC; Califf RM; Ellis SG; Sigmon K; Kereiakes D; George BS; Samaha J; Sane D; Stump DC; Stack RS
    J Am Coll Cardiol; 1993 Mar; 21(3):597-603. PubMed ID: 8436740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
    Van de Werf F; Arnold AE
    BMJ; 1988 Nov; 297(6660):1374-9. PubMed ID: 3146370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
    Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
    N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.
    Rao AK; Pratt C; Berke A; Jaffe A; Ockene I; Schreiber TL; Bell WR; Knatterud G; Robertson TL; Terrin ML
    J Am Coll Cardiol; 1988 Jan; 11(1):1-11. PubMed ID: 3121710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endovenous thrombolysis in acute myocardial infarct. The experience in a community hospital. An analysis of 120 patients].
    Jorge Sdo C
    Arq Bras Cardiol; 1992 Jul; 59(1):23-30. PubMed ID: 1341143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related efficacy and bleeding complications of double-chain tissue plasminogen activator in acute myocardial infarction. The Wellcome Tissue Plasminogen Activator Study Group.
    Turi ZG; Goldberg S; LittleJohn JK; Vander Ark C; Shadoff N; Karlsberg R; Williams J; Butman S; Stadius ML; Wise K
    Am J Cardiol; 1993 May; 71(12):1009-14. PubMed ID: 8475860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators.
    Berkowitz SD; Granger CB; Pieper KS; Lee KL; Gore JM; Simoons M; Armstrong PW; Topol EJ; Califf RM
    Circulation; 1997 Jun; 95(11):2508-16. PubMed ID: 9184581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction.
    Topol EJ; Califf RM; George BS; Kereiakes DJ; Abbottsmith CW; Candela RJ; Lee KL; Pitt B; Stack RS; O'Neill WW
    N Engl J Med; 1987 Sep; 317(10):581-8. PubMed ID: 2956516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose finding with a novel recombinant plasminogen activator (BM 06.022) in patients with acute myocardial infarction: results of the German Recombinant Plasminogen Activator Study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK).
    Neuhaus KL; von Essen R; Vogt A; Tebbe U; Rustige J; Wagner HJ; Appel KF; Stienen U; König R; Meyer-Sabellek W
    J Am Coll Cardiol; 1994 Jul; 24(1):55-60. PubMed ID: 8006283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clot-selective coronary thrombolysis with low-dose synergistic combinations of single-chain urokinase-type plasminogen activator and recombinant tissue-type plasminogen activator. The Pro-Urokinase for Myocardial Infarction Study Group.
    Kirshenbaum JM; Bahr RD; Flaherty JT; Gurewich V; Levine HJ; Loscalzo J; Schumacher RR; Topol EJ; Wahr DW; Braunwald E
    Am J Cardiol; 1991 Dec; 68(17):1564-9. PubMed ID: 1746455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
    Gimple LW; Gold HK; Leinbach RC; Coller BS; Werner W; Yasuda T; Johns JA; Ziskind AA; Finkelstein D; Collen D
    Circulation; 1989 Sep; 80(3):581-8. PubMed ID: 2504511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
    J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction.
    Topol EJ; Morris DC; Smalling RW; Schumacher RR; Taylor CR; Nishikawa A; Liberman HA; Collen D; Tufte ME; Grossbard EB
    J Am Coll Cardiol; 1987 Jun; 9(6):1205-13. PubMed ID: 2953770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum levels of fibrinogen degradation products due to treatment with recombinant tissue-type plasminogen activator for acute myocardial infarction are related to bleeding complications, but not to coronary patency. European Co-operative Study Groups for rt-PA.
    Arnold AE; Brower RW; Collen D; van Es GA; Lubsen J; Serruys PW; Simoons ML; Verstraete M
    J Am Coll Cardiol; 1989 Sep; 14(3):581-8. PubMed ID: 2504798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two dose regimens of intravenous tissue plasminogen activator for acute myocardial infarction.
    Topol EJ; George BS; Kereiakes DJ; Candela RJ; Abbottsmith CW; Stump DC; Boswick JM; Stack RS; Califf RM
    Am J Cardiol; 1988 Apr; 61(10):723-8. PubMed ID: 2965504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. The STAR Trial Group.
    Vanderschueren S; Barrios L; Kerdsinchai P; Van den Heuvel P; Hermans L; Vrolix M; De Man F; Benit E; Muyldermans L; Collen D
    Circulation; 1995 Oct; 92(8):2044-9. PubMed ID: 7554180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.